Insider · CIK 0001967163

Patel Anish

Reports to the SEC for 1 company · BOULDER, CO

sec.gov

Transactions

Companies

Filings

CIK

0001967163

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-02-12	ELVNEnliven Therapeutics, Inc.A Award	CHIEF OPERATING OFFICER	AAward	+20K sh	—	—	20,000
2026-02-12	ELVNEnliven Therapeutics, Inc. · Stock Option (right to buy)A Award	CHIEF OPERATING OFFICER	AAward	+120K sh	—	—	120,000
2026-01-09	ELVNEnliven Therapeutics, Inc.S Sale	CHIEF OPERATING OFFICER	SSale	−48.1K sh	$27.98	−$1.34M	215,254
2026-01-09	ELVNEnliven Therapeutics, Inc.S Sale	CHIEF OPERATING OFFICER	SSale	−243 sh	$28.50	−$6,925.5	215,011
2025-12-08	ELVNEnliven Therapeutics, Inc.S Sale	CHIEF OPERATING OFFICER	SSale	−4,958 sh	$20.76	−$103K	265,016
2025-12-08	ELVNEnliven Therapeutics, Inc.S Sale	CHIEF OPERATING OFFICER	SSale	−1,705 sh	$21.78	−$37.1K	263,311
2025-11-07	ELVNEnliven Therapeutics, Inc.S Sale	CHIEF OPERATING OFFICER	SSale	−6,054 sh	$17.35	−$105K	270,587
2025-11-07	ELVNEnliven Therapeutics, Inc.S Sale	CHIEF OPERATING OFFICER	SSale	−613 sh	$17.94	−$11K	269,974
2025-10-07	ELVNEnliven Therapeutics, Inc.S Sale	CHIEF OPERATING OFFICER	SSale	−6,667 sh	$20.10	−$134K	276,641
2025-09-08	ELVNEnliven Therapeutics, Inc.S Sale	CHIEF OPERATING OFFICER	SSale	−6,667 sh	$20.24	−$135K	283,308
2025-08-07	ELVNEnliven Therapeutics, Inc.S Sale	CHIEF OPERATING OFFICER	SSale	−6,262 sh	$18.20	−$114K	290,380
2025-08-07	ELVNEnliven Therapeutics, Inc.S Sale	CHIEF OPERATING OFFICER	SSale	−405 sh	$18.93	−$7,666.529	289,975
2025-07-07	ELVNEnliven Therapeutics, Inc.S Sale	CHIEF OPERATING OFFICER	SSale	−6,362 sh	$19.75	−$126K	296,947
2025-07-07	ELVNEnliven Therapeutics, Inc.S Sale	CHIEF OPERATING OFFICER	SSale	−305 sh	$20.69	−$6,311.914	296,642
2025-06-09	ELVNEnliven Therapeutics, Inc.S Sale	CHIEF OPERATING OFFICER	SSale	−6,607 sh	$20.33	−$134K	303,369
2025-06-09	ELVNEnliven Therapeutics, Inc.S Sale	CHIEF OPERATING OFFICER	SSale	−60 sh	$21.16	−$1,269.6	303,309
2025-05-07	ELVNEnliven Therapeutics, Inc.S Sale	CHIEF OPERATING OFFICER	SSale	−6,173 sh	$18.30	−$113K	310,470
2025-05-07	ELVNEnliven Therapeutics, Inc.S Sale	CHIEF OPERATING OFFICER	SSale	−390 sh	$19.40	−$7,565.415	310,080
2025-05-07	ELVNEnliven Therapeutics, Inc.S Sale	CHIEF OPERATING OFFICER	SSale	−104 sh	$19.87	−$2,066.678	309,976
2025-04-07	ELVNEnliven Therapeutics, Inc.S Sale	CHIEF OPERATING OFFICER	SSale	−3,756 sh	$17.81	−$66.9K	319,554
2025-04-07	ELVNEnliven Therapeutics, Inc.S Sale	CHIEF OPERATING OFFICER	SSale	−2,763 sh	$18.29	−$50.5K	316,791
2025-04-07	ELVNEnliven Therapeutics, Inc.S Sale	CHIEF OPERATING OFFICER	SSale	−148 sh	$19.27	−$2,852.271	316,643
2025-03-07	ELVNEnliven Therapeutics, Inc.S Sale	CHIEF OPERATING OFFICER	SSale	−6,667 sh	$21.44	−$143K	323,310
2025-02-07	ELVNEnliven Therapeutics, Inc.S Sale	CHIEF OPERATING OFFICER	SSale	−6,667 sh	$21.93	−$146K	329,977
2025-02-06	ELVNEnliven Therapeutics, Inc. · Stock Option (right to buy)A Award	CHIEF OPERATING OFFICER	AAward	+171K sh	—	—	171,000
2025-01-07	ELVNEnliven Therapeutics, Inc.M Exercise/Conversion	CHIEF OPERATING OFFICER	MExercise/Conversion	+10.7K sh	$1.12	+$12K	10,700
2025-01-07	ELVNEnliven Therapeutics, Inc.M Exercise/Conversion	CHIEF OPERATING OFFICER	MExercise/Conversion	+2,000 sh	$2.48	+$4,960	12,700
2025-01-07	ELVNEnliven Therapeutics, Inc.M Exercise/Conversion	CHIEF OPERATING OFFICER	MExercise/Conversion	+9,000 sh	$2.48	+$22.3K	21,700
2025-01-07	ELVNEnliven Therapeutics, Inc.S Sale	CHIEF OPERATING OFFICER	SSale	−20.3K sh	$24.15	−$489K	1,440
2025-01-07	ELVNEnliven Therapeutics, Inc.S Sale	CHIEF OPERATING OFFICER	SSale	−1,440 sh	$24.56	−$35.4K	0
2025-01-07	ELVNEnliven Therapeutics, Inc.S Sale	CHIEF OPERATING OFFICER	SSale	−6,577 sh	$24.17	−$159K	336,734
2025-01-07	ELVNEnliven Therapeutics, Inc.S Sale	CHIEF OPERATING OFFICER	SSale	−90 sh	$24.60	−$2,214.072	336,644
2025-01-07	ELVNEnliven Therapeutics, Inc. · Employee Stock Option (right to buy)M Exercise/Conversion	CHIEF OPERATING OFFICER	MExercise/Conversion	−10.7K sh	—	—	67
2025-01-07	ELVNEnliven Therapeutics, Inc. · Employee Stock Option (right to buy)M Exercise/Conversion	CHIEF OPERATING OFFICER	MExercise/Conversion	−2,000 sh	—	—	827
2025-01-07	ELVNEnliven Therapeutics, Inc. · Employee Stock Option (right to buy)M Exercise/Conversion	CHIEF OPERATING OFFICER	MExercise/Conversion	−9,000 sh	—	—	44,342
2024-10-18	ELVNEnliven Therapeutics, Inc.S Sale	CHIEF OPERATING OFFICER	SSale	−716 sh	$30.00	−$21.5K	343,311
2024-07-16	ELVNEnliven Therapeutics, Inc.S Sale	CHIEF OPERATING OFFICER	SSale	−1,547 sh	$25.01	−$38.7K	344,027
2024-07-15	ELVNEnliven Therapeutics, Inc.S Sale	CHIEF OPERATING OFFICER	SSale	−31K sh	$25.05	−$776K	345,574
2024-07-12	ELVNEnliven Therapeutics, Inc.S Sale	CHIEF OPERATING OFFICER	SSale	−17.5K sh	$25.07	−$438K	376,552
2024-06-06	ELVNEnliven Therapeutics, Inc.M Exercise/Conversion	CHIEF OPERATING OFFICER	MExercise/Conversion	+1,133 sh	$2.48	+$2,809.84	1,133
2024-06-06	ELVNEnliven Therapeutics, Inc.S Sale	CHIEF OPERATING OFFICER	SSale	−1,133 sh	$20.06	−$22.7K	0
2024-06-06	ELVNEnliven Therapeutics, Inc. · Employee Stock Option (right to buy)M Exercise/Conversion	CHIEF OPERATING OFFICER	MExercise/Conversion	−1,133 sh	—	—	53,342
2024-05-14	ELVNEnliven Therapeutics, Inc.M Exercise/Conversion	CHIEF OPERATING OFFICER	MExercise/Conversion	+1,107 sh	$2.48	+$2,745.36	1,107
2024-05-14	ELVNEnliven Therapeutics, Inc.S Sale	CHIEF OPERATING OFFICER	SSale	−1,107 sh	$25.00	−$27.7K	0
2024-05-14	ELVNEnliven Therapeutics, Inc. · Employee Stock Option (right to buy)M Exercise/Conversion	CHIEF OPERATING OFFICER	MExercise/Conversion	−1,107 sh	—	—	54,475
2024-05-09	ELVNEnliven Therapeutics, Inc.M Exercise/Conversion	CHIEF OPERATING OFFICER	MExercise/Conversion	+260 sh	$2.48	+$644.8	260
2024-05-09	ELVNEnliven Therapeutics, Inc.S Sale	CHIEF OPERATING OFFICER	SSale	−260 sh	$25.06	−$6,515.496	0
2024-05-09	ELVNEnliven Therapeutics, Inc. · Employee Stock Option (right to buy)M Exercise/Conversion	CHIEF OPERATING OFFICER	MExercise/Conversion	−260 sh	—	—	55,582
2024-05-06	ELVNEnliven Therapeutics, Inc.M Exercise/Conversion	CHIEF OPERATING OFFICER	MExercise/Conversion	+4,875 sh	$2.48	+$12.1K	4,875
2024-05-06	ELVNEnliven Therapeutics, Inc.S Sale	CHIEF OPERATING OFFICER	SSale	−4,875 sh	$22.72	−$111K	0

Recent filings

Accepted (ET)
Feb 174
Patel Anish0001967163-26-000002
SEC(opens sec.gov)
Jan 134
Patel Anish0001967163-26-000001
SEC(opens sec.gov)
Dec 104
Patel Anish0001967163-25-000005
SEC(opens sec.gov)
Nov 124
Patel Anish0001967163-25-000004
SEC(opens sec.gov)
Oct 94
Patel Anish0001967163-25-000003
SEC(opens sec.gov)
Sep 104
Patel Anish0001415889-25-024196
SEC(opens sec.gov)
Aug 114
Patel Anish0001415889-25-021456
SEC(opens sec.gov)
Jul 94
Patel Anish0001415889-25-019609
SEC(opens sec.gov)
Jun 114
Patel Anish0001415889-25-016734
SEC(opens sec.gov)
May 94
Patel Anish0001415889-25-012591
SEC(opens sec.gov)
Apr 94
Patel Anish0001415889-25-010474
SEC(opens sec.gov)

Companies

Enliven Therapeutics, Inc.CHIEF OPERATING OFFICERELVN

Address

C/O ENLIVEN THERAPEUTICS, INC. 6200 LOOKOUT ROAD

BOULDER, CO, 80301